Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)—its relation to metabolic control
- 1 January 2004
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 113 (2) , 101-113
- https://doi.org/10.1016/j.thromres.2003.12.016
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Pharmacokinetic and Pharmacodynamic Differences Between Two Low Dosages of Aspirin May Affect Therapeutic OutcomesClinical Pharmacokinetics, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Aspirin Therapy in DiabetesDiabetes Care, 2002
- Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistanceThe Lancet, 1999
- Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patientsDiabetes, 1997
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Relationship of platelet aggregation to bleeding after cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Failure of aspirin treatment after stroke.Stroke, 1994
- European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.Stroke, 1992
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990